Viewing Study NCT05895695


Ignite Creation Date: 2025-12-24 @ 2:12 PM
Ignite Modification Date: 2025-12-24 @ 2:12 PM
Study NCT ID: NCT05895695
Status: UNKNOWN
Last Update Posted: 2023-06-08
First Post: 2023-05-11
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Levator Muscle Reaction for Unilateral Congenital Ptosis Repair as Compared to Levator Plication
Sponsor: Sohag University
Organization:

Study Overview

Official Title: Levator Muscle Resection for Unilateral Congenital Ptosis Repair as Compared to Levator Plication
Status: UNKNOWN
Status Verified Date: 2023-06
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of this study was to compare the outcome of levator muscle resection with plication in mild to moderate congenital unilateral blepharoptosis.
Detailed Description: Blepharotosis is one of the most encountered oculoplastic problems. Blepharoptosis is an abnormal low lying upper eyelid margin more than 2mm below the superior corneal limbus in the primary gaze position.

It can be subdivided according to the amount of levator function into poor (0-5),fair (6-11) or good (12 or more) millimeter. It can be classified also according to the degree of ptosis into mild (2mm) moderate (3mm) and severe ( 4mm or more). Surgical options for each of these groups are based on levator function as well as the degree and the cause of ptosis.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: